Stock Groups

EU regulator lists new side-effect of J&J COVID-19 shot -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILE PHOTO: Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/File Photo

(Reuters) – Europe’s drug regulator on Thursday recommended addition of a rare type of spinal inflammation as a side-effect of Johnson & Johnson (NYSE:)’s COVID-19 vaccine.

The team also evaluated reports of capillary leak syndrome after inoculation. Moderna (NASDAQ)’s shot.

European Medicines Agency stated that currently, not enough evidence exists to link rare multisystem inflammation syndrome cases with moderna’s shot.

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by market makers. As such, they may be incorrect and different from market price. This means that prices cannot be used to trade. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]